Literature DB >> 18983219

Smoking cessation in pregnancy.

Craig Rore1, Vicki Brace, Peter Danielian, David Williams.   

Abstract

BACKGROUND: Pregnant women who continue to smoke expose their developing fetus to a wide range of risks. Assisting these patients to stop smoking can be an important intervention for the health of the baby and the mother. The management of pregnant smokers can be challenging, due to the potential risks of pharmacotherapy. There are a number of options available to the clinician to aid smoking cessation in non pregnant women. These include nicotine replacement therapy (NRT), bupropion, varenicline, and a range of non-drug therapies.
OBJECTIVE: To provide guidance to prescribers on the best way to manage smoking cessation in the pregnant patient, reviewing the risks and efficacy of the different approaches.
METHODS: An extensive literature search was carried out to find original studies which examined issues surrounding the safety and efficacy of methods of smoking cessation in pregnancy. RESULTS/
CONCLUSION: NRT is the agent of choice for smoking cessation in pregnancy as the safety of other therapies in pregnancy have not yet been proved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983219     DOI: 10.1517/14740330802196756

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  4 in total

1.  Pharmacological interventions for promoting smoking cessation during pregnancy.

Authors:  Ravinder Claire; Catherine Chamberlain; Mary-Ann Davey; Sue E Cooper; Ivan Berlin; Jo Leonardi-Bee; Tim Coleman
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

2.  Preventing smoking during pregnancy: the importance of maternal knowledge of the health hazards and of the treatment options available.

Authors:  André Luís Bertani; Thais Garcia; Suzana Erico Tanni; Irma Godoy
Journal:  J Bras Pneumol       Date:  2015 Mar-Apr       Impact factor: 2.624

Review 3.  A systematic review of possible serious adverse health effects of nicotine replacement therapy.

Authors:  Peter N Lee; Marc W Fariss
Journal:  Arch Toxicol       Date:  2016-10-03       Impact factor: 5.153

Review 4.  HIV-infected adolescent, young adult and pregnant smokers: important targets for effective tobacco control programs.

Authors:  Gerome Escota; Nur Onen
Journal:  Int J Environ Res Public Health       Date:  2013-06-18       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.